ArticleTherapeutic advances in neurological disorders2026
Adherence to risk minimization measures for alemtuzumab use in multiple sclerosis: a drug utilization study in four European countries.
Carmen de Keijzer et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.